Upstream Biosciences Inc. Seeks Licensors or Acquirers for Drug Discovery Portfolio and Cancer Diagnostic Platform

Published: Aug 10, 2009

VANCOUVER, British Columbia--(BUSINESS WIRE)--Upstream Biosciences Inc. (OTCBB: UPBS) today announced that the company is actively seeking licensors or acquirers for its novel anti-parasitic drug discovery portfolio and cancer diagnostic platform.

Back to news